1Chen Y,Trotti A,Coleman CN,et al.Adverse event reporting and developments in radiation biology after normal tissue injury:International Atomic Energy Agency consultation.Int J Radiat Oncol Biol Phys,2006,64(5):1442-1451.
2Turesson I,Nyman J,Holmberg E,et al.Prognostic factors for acute and late skin reactions in radiotherapy patients.Int J Radiat Oncol B iol Phys,1996,36 (5):1065-1075.
3Beamish H,Kedar P,Kaneko H,et al.Functional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasiamutated protein,ATM.J Biol Chem,2002,277 (34):30515-30523.
4Djuzenova CS,Rothfuss A,Oppitz U,et al.Response to Xirradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay.Lab Invest,2001,81 (2):185-192.
5Carney JP,Maser RS,Olivares H,et al.The hMre11/hRad50 protein complex and Nijmegen breakage syndrome:linkage of double-strand break repair to the cellular DNA damage response.Cell,1998,93 (3):477-486.
6Baskaran R,Wood LD,Whitaker LL,et al.Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation.Nature,1997,387 (6632):516.
8Bag A,Bag N.Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk:a review.Cancer Epidemiol Biomarkers Prev,2008,17 (12):3298-3305.
9Green H,Ross G,Peacock J,et al.Variation in the manganese superoxide dismutase gene (SOD2) is not a major cause of radiotherapy complications in breast cancer patients.Radiother Oncol,2002,63 (2):213-216.
10Andreassen CN,Alsner J,Overgaard M,et al.Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes.Radiother Oncol,2003,69(2):127-135.
5Blot WJ, McLaughlin JK. Passive smoking and lung cancer risk: What is the study now? [J]. J Natl Cancer Inst, 1998,90: 1416-1425.
6Mitsudomi T, Takahashi T. Genetic abnormalities in lung cancer and their prognostic implications [J]. Gan To Kagaku Ryoho, 1996, 23 (8): 990-996.
7Michael B, Onyinye O, David S, et al. Participation of p53 protein in the cellular response to DNA damage [J]. Cancer Res, 1991, 51: 6304-6307.
8Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation [J]. Ann N Y Acad Sci, 2000,910: 121-137.
9Fujita T, Kiyama M, Tomizawa Y, et al. Comprehensive analysis of p53 gene mutation characteristics in lung cancinoma with special reference to histological subtypes [J].Int J Oncol, 1999, 15: 927-933.
10Figueras J, Gene M, Catalan J, et al. Glutathione Transferase M1 and codon 72 p53 polymorphism in a north-western Mediterranean population and their relation to lung cancer susceptibility [J]. Cancer Epidemic Biomarker Prey, 1996, 5:337-342.
